nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—HTR2C—obesity	0.0605	0.304	CbGaD
Doxepin—SLC6A4—obesity	0.0501	0.252	CbGaD
Doxepin—DRD2—obesity	0.0499	0.251	CbGaD
Doxepin—HTR2A—obesity	0.0385	0.194	CbGaD
Doxepin—Cyclobenzaprine—Benzphetamine—obesity	0.027	0.113	CrCrCtD
Doxepin—Doxylamine—Benzphetamine—obesity	0.0248	0.104	CrCrCtD
Doxepin—HRH2—Cimetidine—obesity	0.0228	0.0624	CbGbCtD
Doxepin—Tripelennamine—Benzphetamine—obesity	0.0224	0.0941	CrCrCtD
Doxepin—Trimipramine—Benzphetamine—obesity	0.0219	0.092	CrCrCtD
Doxepin—SLC6A2—Diethylpropion—obesity	0.0218	0.0596	CbGbCtD
Doxepin—Bromodiphenhydramine—Benzphetamine—obesity	0.021	0.088	CrCrCtD
Doxepin—Pheniramine—Benzphetamine—obesity	0.0205	0.0861	CrCrCtD
Doxepin—SLC6A4—Sibutramine—obesity	0.0197	0.054	CbGbCtD
Doxepin—Promethazine—Benzphetamine—obesity	0.0186	0.078	CrCrCtD
Doxepin—Alimemazine—Benzphetamine—obesity	0.0183	0.0766	CrCrCtD
Doxepin—ADRA1B—Phendimetrazine—obesity	0.0181	0.0494	CbGbCtD
Doxepin—Clofedanol—Benzphetamine—obesity	0.017	0.0714	CrCrCtD
Doxepin—SLC6A2—Phendimetrazine—obesity	0.0165	0.0451	CbGbCtD
Doxepin—SLC6A2—Sibutramine—obesity	0.0165	0.0451	CbGbCtD
Doxepin—Orphenadrine—Benzphetamine—obesity	0.0165	0.0691	CrCrCtD
Doxepin—Promazine—Benzphetamine—obesity	0.0157	0.066	CrCrCtD
Doxepin—ORM1—Bupropion—obesity	0.0154	0.0421	CbGbCtD
Doxepin—SLC6A4—Phentermine—obesity	0.015	0.0409	CbGbCtD
Doxepin—Diphenhydramine—Benzphetamine—obesity	0.0146	0.0614	CrCrCtD
Doxepin—ADRA1A—Phendimetrazine—obesity	0.0143	0.039	CbGbCtD
Doxepin—ADRA2C—Methamphetamine—obesity	0.0137	0.0374	CbGbCtD
Doxepin—ADRA2B—Methamphetamine—obesity	0.013	0.0354	CbGbCtD
Doxepin—SLC6A2—Phentermine—obesity	0.0125	0.0342	CbGbCtD
Doxepin—SLC6A2—Benzphetamine—obesity	0.0125	0.0342	CbGbCtD
Doxepin—SLC6A4—Methamphetamine—obesity	0.012	0.0327	CbGbCtD
Doxepin—SLC6A2—Phenylpropanolamine—obesity	0.0119	0.0326	CbGbCtD
Doxepin—ADRA2A—Benzphetamine—obesity	0.0113	0.0308	CbGbCtD
Doxepin—ADRA1A—Benzphetamine—obesity	0.0108	0.0296	CbGbCtD
Doxepin—ADRA2A—Phenylpropanolamine—obesity	0.0108	0.0294	CbGbCtD
Doxepin—SLC6A2—Bupropion—obesity	0.0106	0.0291	CbGbCtD
Doxepin—ADRA1A—Phenylpropanolamine—obesity	0.0103	0.0282	CbGbCtD
Doxepin—SLC6A2—Methamphetamine—obesity	0.01	0.0273	CbGbCtD
Doxepin—ADRA2A—Methamphetamine—obesity	0.00901	0.0247	CbGbCtD
Doxepin—CYP1A2—Phentermine—obesity	0.00455	0.0124	CbGbCtD
Doxepin—CYP1A2—Phenylpropanolamine—obesity	0.00434	0.0119	CbGbCtD
Doxepin—CYP2C9—Phentermine—obesity	0.0041	0.0112	CbGbCtD
Doxepin—CYP1A2—Bupropion—obesity	0.00387	0.0106	CbGbCtD
Doxepin—CYP2D6—Phentermine—obesity	0.00375	0.0103	CbGbCtD
Doxepin—CYP2C9—Bupropion—obesity	0.00349	0.00954	CbGbCtD
Doxepin—CYP2D6—Bupropion—obesity	0.00319	0.00872	CbGbCtD
Doxepin—CYP3A4—Sibutramine—obesity	0.00315	0.00861	CbGbCtD
Doxepin—CYP2C19—Cimetidine—obesity	0.00308	0.00842	CbGbCtD
Doxepin—CYP2D6—Methamphetamine—obesity	0.003	0.0082	CbGbCtD
Doxepin—CYP1A2—Cimetidine—obesity	0.00284	0.00777	CbGbCtD
Doxepin—CYP2C9—Cimetidine—obesity	0.00256	0.007	CbGbCtD
Doxepin—ABCB1—Cimetidine—obesity	0.00248	0.00679	CbGbCtD
Doxepin—CYP3A4—Benzphetamine—obesity	0.00238	0.00652	CbGbCtD
Doxepin—CYP2D6—Cimetidine—obesity	0.00234	0.0064	CbGbCtD
Doxepin—CYP3A4—Bupropion—obesity	0.00203	0.00555	CbGbCtD
Doxepin—CYP2C19—Topiramate—obesity	0.00201	0.00551	CbGbCtD
Doxepin—ORM1—bile—obesity	0.00185	0.0805	CbGeAlD
Doxepin—CHRM3—muscle of abdomen—obesity	0.0017	0.0738	CbGeAlD
Doxepin—CYP3A4—Orlistat—obesity	0.00165	0.00452	CbGbCtD
Doxepin—CYP3A4—Cimetidine—obesity	0.00149	0.00407	CbGbCtD
Doxepin—SLC6A2—sympathetic nervous system—obesity	0.00138	0.06	CbGeAlD
Doxepin—CYP3A4—Topiramate—obesity	0.000974	0.00266	CbGbCtD
Doxepin—SLC6A2—autonomic nervous system—obesity	0.000928	0.0404	CbGeAlD
Doxepin—HTR2A—sympathetic nervous system—obesity	0.00083	0.0361	CbGeAlD
Doxepin—HTR2A—vagus nerve—obesity	0.000803	0.0349	CbGeAlD
Doxepin—HTR2A—autonomic nervous system—obesity	0.000558	0.0243	CbGeAlD
Doxepin—ORM1—gall bladder—obesity	0.000514	0.0224	CbGeAlD
Doxepin—SLC6A4—hindbrain—obesity	0.000444	0.0193	CbGeAlD
Doxepin—HTR1A—hindbrain—obesity	0.000394	0.0171	CbGeAlD
Doxepin—ADRA1A—hindbrain—obesity	0.000363	0.0158	CbGeAlD
Doxepin—DRD2—hindbrain—obesity	0.000356	0.0155	CbGeAlD
Doxepin—HRH2—cardiovascular system—obesity	0.000347	0.0151	CbGeAlD
Doxepin—HRH2—digestive system—obesity	0.000288	0.0125	CbGeAlD
Doxepin—HRH2—adrenal gland—obesity	0.000274	0.0119	CbGeAlD
Doxepin—SLC6A4—respiratory system—obesity	0.000271	0.0118	CbGeAlD
Doxepin—SLC6A2—respiratory system—obesity	0.000239	0.0104	CbGeAlD
Doxepin—HRH2—endocrine gland—obesity	0.000238	0.0103	CbGeAlD
Doxepin—HTR2A—hindbrain—obesity	0.000235	0.0102	CbGeAlD
Doxepin—CHRM2—cardiovascular system—obesity	0.000227	0.00988	CbGeAlD
Doxepin—KCNH2—islet of Langerhans—obesity	0.000227	0.00987	CbGeAlD
Doxepin—HTR2B—adrenal cortex—obesity	0.000225	0.00981	CbGeAlD
Doxepin—DRD2—respiratory system—obesity	0.000218	0.00946	CbGeAlD
Doxepin—HRH2—liver—obesity	0.000214	0.00932	CbGeAlD
Doxepin—CYP2D6—hindbrain—obesity	0.000214	0.00931	CbGeAlD
Doxepin—CHRM1—cardiovascular system—obesity	0.000207	0.009	CbGeAlD
Doxepin—HTR2B—cardiovascular system—obesity	0.000206	0.00895	CbGeAlD
Doxepin—ADRA1D—endocrine gland—obesity	0.000203	0.00883	CbGeAlD
Doxepin—HTR1A—cardiovascular system—obesity	0.000184	0.00802	CbGeAlD
Doxepin—CYP1A2—respiratory system—obesity	0.000183	0.00798	CbGeAlD
Doxepin—HTR2B—adipose tissue—obesity	0.000181	0.00789	CbGeAlD
Doxepin—ADRA2A—islet of Langerhans—obesity	0.000179	0.00777	CbGeAlD
Doxepin—ADRA2C—adrenal cortex—obesity	0.000177	0.00772	CbGeAlD
Doxepin—SLC6A4—digestive system—obesity	0.000172	0.0075	CbGeAlD
Doxepin—HRH1—respiratory system—obesity	0.000172	0.00747	CbGeAlD
Doxepin—HTR2B—digestive system—obesity	0.000171	0.00743	CbGeAlD
Doxepin—ADRA1A—cardiovascular system—obesity	0.00017	0.00739	CbGeAlD
Doxepin—ORM1—endocrine gland—obesity	0.000167	0.00727	CbGeAlD
Doxepin—KCNH2—cardiovascular system—obesity	0.000164	0.00714	CbGeAlD
Doxepin—CHRM3—adipose tissue—obesity	0.000163	0.0071	CbGeAlD
Doxepin—HTR2B—adrenal gland—obesity	0.000163	0.00708	CbGeAlD
Doxepin—CHRM2—endocrine gland—obesity	0.000156	0.00678	CbGeAlD
Doxepin—CHRM3—digestive system—obesity	0.000154	0.00668	CbGeAlD
Doxepin—ORM1—liver—obesity	0.000151	0.00656	CbGeAlD
Doxepin—ADRA1A—adipose tissue—obesity	0.00015	0.00652	CbGeAlD
Doxepin—DRD2—pituitary gland—obesity	0.000148	0.00642	CbGeAlD
Doxepin—HTR1A—adrenal gland—obesity	0.000146	0.00634	CbGeAlD
Doxepin—KCNH2—pituitary gland—obesity	0.000145	0.00632	CbGeAlD
Doxepin—SLC6A2—adrenal gland—obesity	0.000145	0.00629	CbGeAlD
Doxepin—HTR2A—respiratory system—obesity	0.000143	0.00624	CbGeAlD
Doxepin—ADRA2C—pituitary gland—obesity	0.000143	0.00624	CbGeAlD
Doxepin—CYP2C19—digestive system—obesity	0.000143	0.00621	CbGeAlD
Doxepin—ADRA2C—adipose tissue—obesity	0.000143	0.00621	CbGeAlD
Doxepin—SLC6A4—endocrine gland—obesity	0.000142	0.0062	CbGeAlD
Doxepin—CHRM1—endocrine gland—obesity	0.000142	0.00617	CbGeAlD
Doxepin—Amitriptyline—NTRK2—obesity	0.000135	0.0693	CrCbGaD
Doxepin—ADRA1A—adrenal gland—obesity	0.000134	0.00585	CbGeAlD
Doxepin—CYP2C9—cardiovascular system—obesity	0.000133	0.0058	CbGeAlD
Doxepin—KCNH2—adrenal gland—obesity	0.00013	0.00565	CbGeAlD
Doxepin—ADRA2C—adrenal gland—obesity	0.000128	0.00557	CbGeAlD
Doxepin—CHRM3—endocrine gland—obesity	0.000127	0.00552	CbGeAlD
Doxepin—HTR1A—endocrine gland—obesity	0.000126	0.0055	CbGeAlD
Doxepin—SLC6A2—endocrine gland—obesity	0.000125	0.00545	CbGeAlD
Doxepin—CYP2C19—endocrine gland—obesity	0.000118	0.00513	CbGeAlD
Doxepin—CYP1A2—digestive system—obesity	0.000117	0.00507	CbGeAlD
Doxepin—ADRA1A—endocrine gland—obesity	0.000117	0.00507	CbGeAlD
Doxepin—HRH1—adipose tissue—obesity	0.000116	0.00505	CbGeAlD
Doxepin—ADRA2A—pituitary gland—obesity	0.000114	0.00498	CbGeAlD
Doxepin—DRD2—endocrine gland—obesity	0.000114	0.00497	CbGeAlD
Doxepin—ADRA2A—adipose tissue—obesity	0.000114	0.00496	CbGeAlD
Doxepin—KCNH2—endocrine gland—obesity	0.000113	0.0049	CbGeAlD
Doxepin—CYP2C9—digestive system—obesity	0.000111	0.00482	CbGeAlD
Doxepin—HTR2A—cardiovascular system—obesity	0.00011	0.00478	CbGeAlD
Doxepin—HRH1—digestive system—obesity	0.000109	0.00475	CbGeAlD
Doxepin—CYP2C19—liver—obesity	0.000106	0.00463	CbGeAlD
Doxepin—ADRA1A—liver—obesity	0.000105	0.00457	CbGeAlD
Doxepin—HRH1—adrenal gland—obesity	0.000104	0.00453	CbGeAlD
Doxepin—ADRA2A—adrenal gland—obesity	0.000102	0.00445	CbGeAlD
Doxepin—ADRA2C—liver—obesity	0.0001	0.00436	CbGeAlD
Doxepin—ABCB1—islet of Langerhans—obesity	9.96e-05	0.00433	CbGeAlD
Doxepin—HTR2A—pituitary gland—obesity	9.73e-05	0.00423	CbGeAlD
Doxepin—CYP1A2—endocrine gland—obesity	9.64e-05	0.00419	CbGeAlD
Doxepin—ABCB1—respiratory system—obesity	9.4e-05	0.00409	CbGeAlD
Doxepin—CYP2C9—endocrine gland—obesity	9.15e-05	0.00398	CbGeAlD
Doxepin—HTR2A—digestive system—obesity	9.12e-05	0.00397	CbGeAlD
Doxepin—HRH1—endocrine gland—obesity	9.02e-05	0.00392	CbGeAlD
Doxepin—ADRA2A—endocrine gland—obesity	8.86e-05	0.00386	CbGeAlD
Doxepin—HTR2A—adrenal gland—obesity	8.69e-05	0.00378	CbGeAlD
Doxepin—CYP1A2—liver—obesity	8.69e-05	0.00378	CbGeAlD
Doxepin—CYP3A4—digestive system—obesity	8.44e-05	0.00367	CbGeAlD
Doxepin—CYP2D6—digestive system—obesity	8.31e-05	0.00361	CbGeAlD
Doxepin—CYP2C9—liver—obesity	8.25e-05	0.00359	CbGeAlD
Doxepin—ABCB1—adrenal cortex—obesity	7.89e-05	0.00343	CbGeAlD
Doxepin—HTR2A—endocrine gland—obesity	7.54e-05	0.00328	CbGeAlD
Doxepin—Thiothixene—SLC22A1—obesity	7.51e-05	0.0385	CrCbGaD
Doxepin—ABCB1—cardiovascular system—obesity	7.2e-05	0.00313	CbGeAlD
Doxepin—CYP3A4—endocrine gland—obesity	6.98e-05	0.00303	CbGeAlD
Doxepin—CYP2D6—endocrine gland—obesity	6.87e-05	0.00299	CbGeAlD
Doxepin—HTR2A—liver—obesity	6.8e-05	0.00296	CbGeAlD
Doxepin—ABCB1—pituitary gland—obesity	6.38e-05	0.00277	CbGeAlD
Doxepin—ABCB1—adipose tissue—obesity	6.35e-05	0.00276	CbGeAlD
Doxepin—CYP3A4—liver—obesity	6.29e-05	0.00274	CbGeAlD
Doxepin—CYP2D6—liver—obesity	6.19e-05	0.00269	CbGeAlD
Doxepin—Thiothixene—DRD1—obesity	6.14e-05	0.0315	CrCbGaD
Doxepin—Mental disorder—Bupropion—obesity	6.06e-05	0.000661	CcSEcCtD
Doxepin—Urinary retention—Topiramate—obesity	6.06e-05	0.00066	CcSEcCtD
Doxepin—Anxiety—Orlistat—obesity	6.06e-05	0.00066	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	6.04e-05	0.000658	CcSEcCtD
Doxepin—Cough—Sibutramine—obesity	6.03e-05	0.000657	CcSEcCtD
Doxepin—Malnutrition—Bupropion—obesity	6.02e-05	0.000656	CcSEcCtD
Doxepin—Discomfort—Orlistat—obesity	6.01e-05	0.000654	CcSEcCtD
Doxepin—Ataxia—Topiramate—obesity	5.99e-05	0.000653	CcSEcCtD
Doxepin—Convulsion—Sibutramine—obesity	5.99e-05	0.000652	CcSEcCtD
Doxepin—ABCB1—digestive system—obesity	5.98e-05	0.0026	CbGeAlD
Doxepin—Hypertension—Sibutramine—obesity	5.97e-05	0.00065	CcSEcCtD
Doxepin—Dry mouth—Orlistat—obesity	5.94e-05	0.000648	CcSEcCtD
Doxepin—Flatulence—Bupropion—obesity	5.94e-05	0.000647	CcSEcCtD
Doxepin—Tension—Bupropion—obesity	5.91e-05	0.000644	CcSEcCtD
Doxepin—Dysgeusia—Bupropion—obesity	5.9e-05	0.000643	CcSEcCtD
Doxepin—Myalgia—Sibutramine—obesity	5.88e-05	0.000641	CcSEcCtD
Doxepin—Chest pain—Sibutramine—obesity	5.88e-05	0.000641	CcSEcCtD
Doxepin—Arthralgia—Sibutramine—obesity	5.88e-05	0.000641	CcSEcCtD
Doxepin—Anxiety—Sibutramine—obesity	5.86e-05	0.000639	CcSEcCtD
Doxepin—Nervousness—Bupropion—obesity	5.85e-05	0.000638	CcSEcCtD
Doxepin—Oedema—Orlistat—obesity	5.83e-05	0.000635	CcSEcCtD
Doxepin—Back pain—Bupropion—obesity	5.83e-05	0.000635	CcSEcCtD
Doxepin—Discomfort—Sibutramine—obesity	5.81e-05	0.000633	CcSEcCtD
Doxepin—Hypokalaemia—Topiramate—obesity	5.8e-05	0.000632	CcSEcCtD
Doxepin—Muscle spasms—Bupropion—obesity	5.79e-05	0.000631	CcSEcCtD
Doxepin—Infection—Orlistat—obesity	5.79e-05	0.000631	CcSEcCtD
Doxepin—Breast disorder—Topiramate—obesity	5.76e-05	0.000628	CcSEcCtD
Doxepin—Dry mouth—Sibutramine—obesity	5.75e-05	0.000627	CcSEcCtD
Doxepin—Nervous system disorder—Orlistat—obesity	5.71e-05	0.000623	CcSEcCtD
Doxepin—Nasopharyngitis—Topiramate—obesity	5.7e-05	0.000621	CcSEcCtD
Doxepin—ABCB1—adrenal gland—obesity	5.7e-05	0.00248	CbGeAlD
Doxepin—Confusional state—Sibutramine—obesity	5.69e-05	0.00062	CcSEcCtD
Doxepin—Vision blurred—Bupropion—obesity	5.68e-05	0.000619	CcSEcCtD
Doxepin—Skin disorder—Orlistat—obesity	5.66e-05	0.000617	CcSEcCtD
Doxepin—Tremor—Bupropion—obesity	5.64e-05	0.000615	CcSEcCtD
Doxepin—Oedema—Sibutramine—obesity	5.64e-05	0.000615	CcSEcCtD
Doxepin—Hyperhidrosis—Orlistat—obesity	5.63e-05	0.000614	CcSEcCtD
Doxepin—Alanine aminotransferase increased—Topiramate—obesity	5.62e-05	0.000612	CcSEcCtD
Doxepin—Infection—Sibutramine—obesity	5.6e-05	0.00061	CcSEcCtD
Doxepin—Ill-defined disorder—Bupropion—obesity	5.59e-05	0.000609	CcSEcCtD
Doxepin—Anaemia—Bupropion—obesity	5.57e-05	0.000607	CcSEcCtD
Doxepin—Shock—Sibutramine—obesity	5.55e-05	0.000605	CcSEcCtD
Doxepin—Agitation—Bupropion—obesity	5.54e-05	0.000603	CcSEcCtD
Doxepin—Thrombocytopenia—Sibutramine—obesity	5.52e-05	0.000602	CcSEcCtD
Doxepin—Asthma—Topiramate—obesity	5.51e-05	0.0006	CcSEcCtD
Doxepin—Tachycardia—Sibutramine—obesity	5.5e-05	0.0006	CcSEcCtD
Doxepin—Skin disorder—Sibutramine—obesity	5.48e-05	0.000597	CcSEcCtD
Doxepin—Eosinophilia—Topiramate—obesity	5.45e-05	0.000594	CcSEcCtD
Doxepin—Hyperhidrosis—Sibutramine—obesity	5.45e-05	0.000594	CcSEcCtD
Doxepin—Malaise—Bupropion—obesity	5.43e-05	0.000592	CcSEcCtD
Doxepin—Vertigo—Bupropion—obesity	5.41e-05	0.00059	CcSEcCtD
Doxepin—Syncope—Bupropion—obesity	5.4e-05	0.000589	CcSEcCtD
Doxepin—Leukopenia—Bupropion—obesity	5.39e-05	0.000588	CcSEcCtD
Doxepin—Anorexia—Sibutramine—obesity	5.38e-05	0.000586	CcSEcCtD
Doxepin—Diphenhydramine—SLC22A1—obesity	5.36e-05	0.0275	CrCbGaD
Doxepin—Palpitations—Bupropion—obesity	5.32e-05	0.00058	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Orlistat—obesity	5.31e-05	0.000578	CcSEcCtD
Doxepin—Bronchitis—Topiramate—obesity	5.3e-05	0.000577	CcSEcCtD
Doxepin—Loss of consciousness—Bupropion—obesity	5.29e-05	0.000577	CcSEcCtD
Doxepin—Insomnia—Orlistat—obesity	5.27e-05	0.000574	CcSEcCtD
Doxepin—Hypotension—Sibutramine—obesity	5.27e-05	0.000574	CcSEcCtD
Doxepin—Cough—Bupropion—obesity	5.26e-05	0.000573	CcSEcCtD
Doxepin—Thiothixene—HTR2C—obesity	5.25e-05	0.0269	CrCbGaD
Doxepin—Paraesthesia—Orlistat—obesity	5.23e-05	0.00057	CcSEcCtD
Doxepin—Pancytopenia—Topiramate—obesity	5.23e-05	0.00057	CcSEcCtD
Doxepin—Convulsion—Bupropion—obesity	5.22e-05	0.000569	CcSEcCtD
Doxepin—Hypertension—Bupropion—obesity	5.2e-05	0.000567	CcSEcCtD
Doxepin—Dysuria—Topiramate—obesity	5.15e-05	0.000561	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Sibutramine—obesity	5.14e-05	0.00056	CcSEcCtD
Doxepin—Dyspepsia—Orlistat—obesity	5.13e-05	0.000559	CcSEcCtD
Doxepin—Arthralgia—Bupropion—obesity	5.13e-05	0.000559	CcSEcCtD
Doxepin—Myalgia—Bupropion—obesity	5.13e-05	0.000559	CcSEcCtD
Doxepin—Chest pain—Bupropion—obesity	5.13e-05	0.000559	CcSEcCtD
Doxepin—Upper respiratory tract infection—Topiramate—obesity	5.12e-05	0.000558	CcSEcCtD
Doxepin—Anxiety—Bupropion—obesity	5.11e-05	0.000557	CcSEcCtD
Doxepin—Insomnia—Sibutramine—obesity	5.1e-05	0.000556	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	5.09e-05	0.000555	CcSEcCtD
Doxepin—Pollakiuria—Topiramate—obesity	5.09e-05	0.000554	CcSEcCtD
Doxepin—Erectile dysfunction—Topiramate—obesity	5.07e-05	0.000553	CcSEcCtD
Doxepin—Discomfort—Bupropion—obesity	5.07e-05	0.000552	CcSEcCtD
Doxepin—Decreased appetite—Orlistat—obesity	5.07e-05	0.000552	CcSEcCtD
Doxepin—Paraesthesia—Sibutramine—obesity	5.06e-05	0.000552	CcSEcCtD
Doxepin—Cyclobenzaprine—HTR2A—obesity	5.03e-05	0.0258	CrCbGaD
Doxepin—Gastrointestinal disorder—Orlistat—obesity	5.03e-05	0.000548	CcSEcCtD
Doxepin—Dyspnoea—Sibutramine—obesity	5.03e-05	0.000548	CcSEcCtD
Doxepin—Fatigue—Orlistat—obesity	5.02e-05	0.000547	CcSEcCtD
Doxepin—Dry mouth—Bupropion—obesity	5.02e-05	0.000547	CcSEcCtD
Doxepin—Somnolence—Sibutramine—obesity	5.01e-05	0.000546	CcSEcCtD
Doxepin—Weight increased—Topiramate—obesity	5.01e-05	0.000546	CcSEcCtD
Doxepin—Pain—Orlistat—obesity	4.98e-05	0.000543	CcSEcCtD
Doxepin—Dyspepsia—Sibutramine—obesity	4.96e-05	0.000541	CcSEcCtD
Doxepin—Confusional state—Bupropion—obesity	4.96e-05	0.00054	CcSEcCtD
Doxepin—Pneumonia—Topiramate—obesity	4.94e-05	0.000538	CcSEcCtD
Doxepin—ABCB1—endocrine gland—obesity	4.94e-05	0.00215	CbGeAlD
Doxepin—Oedema—Bupropion—obesity	4.92e-05	0.000536	CcSEcCtD
Doxepin—Infestation NOS—Topiramate—obesity	4.91e-05	0.000535	CcSEcCtD
Doxepin—Infestation—Topiramate—obesity	4.91e-05	0.000535	CcSEcCtD
Doxepin—Decreased appetite—Sibutramine—obesity	4.9e-05	0.000534	CcSEcCtD
Doxepin—Infection—Bupropion—obesity	4.88e-05	0.000532	CcSEcCtD
Doxepin—Gastrointestinal disorder—Sibutramine—obesity	4.87e-05	0.000531	CcSEcCtD
Doxepin—Shock—Bupropion—obesity	4.84e-05	0.000527	CcSEcCtD
Doxepin—Chlorprothixene—DRD1—obesity	4.83e-05	0.0248	CrCbGaD
Doxepin—Constipation—Sibutramine—obesity	4.82e-05	0.000525	CcSEcCtD
Doxepin—Pain—Sibutramine—obesity	4.82e-05	0.000525	CcSEcCtD
Doxepin—Nervous system disorder—Bupropion—obesity	4.82e-05	0.000525	CcSEcCtD
Doxepin—Neuropathy peripheral—Topiramate—obesity	4.81e-05	0.000525	CcSEcCtD
Doxepin—Thrombocytopenia—Bupropion—obesity	4.81e-05	0.000525	CcSEcCtD
Doxepin—Feeling abnormal—Orlistat—obesity	4.8e-05	0.000523	CcSEcCtD
Doxepin—Tachycardia—Bupropion—obesity	4.8e-05	0.000523	CcSEcCtD
Doxepin—Stomatitis—Topiramate—obesity	4.79e-05	0.000522	CcSEcCtD
Doxepin—Desipramine—SLC22A1—obesity	4.78e-05	0.0245	CrCbGaD
Doxepin—Skin disorder—Bupropion—obesity	4.78e-05	0.00052	CcSEcCtD
Doxepin—Urinary tract infection—Topiramate—obesity	4.77e-05	0.00052	CcSEcCtD
Doxepin—Gastrointestinal pain—Orlistat—obesity	4.76e-05	0.000519	CcSEcCtD
Doxepin—Hyperhidrosis—Bupropion—obesity	4.75e-05	0.000518	CcSEcCtD
Doxepin—Anorexia—Bupropion—obesity	4.69e-05	0.000511	CcSEcCtD
Doxepin—Feeling abnormal—Sibutramine—obesity	4.65e-05	0.000506	CcSEcCtD
Doxepin—Urticaria—Orlistat—obesity	4.63e-05	0.000504	CcSEcCtD
Doxepin—Gastrointestinal pain—Sibutramine—obesity	4.61e-05	0.000502	CcSEcCtD
Doxepin—Sinusitis—Topiramate—obesity	4.61e-05	0.000502	CcSEcCtD
Doxepin—Abdominal pain—Orlistat—obesity	4.61e-05	0.000502	CcSEcCtD
Doxepin—Body temperature increased—Orlistat—obesity	4.61e-05	0.000502	CcSEcCtD
Doxepin—Hypotension—Bupropion—obesity	4.59e-05	0.000501	CcSEcCtD
Doxepin—Agranulocytosis—Topiramate—obesity	4.58e-05	0.000499	CcSEcCtD
Doxepin—Bradycardia—Topiramate—obesity	4.49e-05	0.000489	CcSEcCtD
Doxepin—Urticaria—Sibutramine—obesity	4.48e-05	0.000488	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Bupropion—obesity	4.48e-05	0.000488	CcSEcCtD
Doxepin—Promazine—DRD4—obesity	4.47e-05	0.0229	CrCbGaD
Doxepin—Abdominal pain—Sibutramine—obesity	4.46e-05	0.000486	CcSEcCtD
Doxepin—Body temperature increased—Sibutramine—obesity	4.46e-05	0.000486	CcSEcCtD
Doxepin—ABCB1—liver—obesity	4.45e-05	0.00194	CbGeAlD
Doxepin—Insomnia—Bupropion—obesity	4.45e-05	0.000485	CcSEcCtD
Doxepin—Paraesthesia—Bupropion—obesity	4.41e-05	0.000481	CcSEcCtD
Doxepin—Hepatitis—Topiramate—obesity	4.41e-05	0.00048	CcSEcCtD
Doxepin—Hypoaesthesia—Topiramate—obesity	4.39e-05	0.000478	CcSEcCtD
Doxepin—Hallucination—Topiramate—obesity	4.39e-05	0.000478	CcSEcCtD
Doxepin—Dyspnoea—Bupropion—obesity	4.38e-05	0.000478	CcSEcCtD
Doxepin—Pharyngitis—Topiramate—obesity	4.38e-05	0.000477	CcSEcCtD
Doxepin—Somnolence—Bupropion—obesity	4.37e-05	0.000476	CcSEcCtD
Doxepin—Urinary tract disorder—Topiramate—obesity	4.35e-05	0.000474	CcSEcCtD
Doxepin—Oedema peripheral—Topiramate—obesity	4.34e-05	0.000473	CcSEcCtD
Doxepin—Connective tissue disorder—Topiramate—obesity	4.33e-05	0.000472	CcSEcCtD
Doxepin—Thiothixene—DRD2—obesity	4.33e-05	0.0222	CrCbGaD
Doxepin—Dyspepsia—Bupropion—obesity	4.33e-05	0.000472	CcSEcCtD
Doxepin—Urethral disorder—Topiramate—obesity	4.32e-05	0.000471	CcSEcCtD
Doxepin—Hypersensitivity—Orlistat—obesity	4.29e-05	0.000468	CcSEcCtD
Doxepin—Decreased appetite—Bupropion—obesity	4.27e-05	0.000466	CcSEcCtD
Doxepin—Gastrointestinal disorder—Bupropion—obesity	4.24e-05	0.000463	CcSEcCtD
Doxepin—Fatigue—Bupropion—obesity	4.24e-05	0.000462	CcSEcCtD
Doxepin—Pain—Bupropion—obesity	4.2e-05	0.000458	CcSEcCtD
Doxepin—Constipation—Bupropion—obesity	4.2e-05	0.000458	CcSEcCtD
Doxepin—Asthenia—Orlistat—obesity	4.18e-05	0.000456	CcSEcCtD
Doxepin—Hypersensitivity—Sibutramine—obesity	4.15e-05	0.000453	CcSEcCtD
Doxepin—Clomipramine—HTR2C—obesity	4.15e-05	0.0213	CrCbGaD
Doxepin—Chlorprothixene—HTR2C—obesity	4.13e-05	0.0212	CrCbGaD
Doxepin—Pruritus—Orlistat—obesity	4.12e-05	0.000449	CcSEcCtD
Doxepin—Eye disorder—Topiramate—obesity	4.12e-05	0.000449	CcSEcCtD
Doxepin—Tinnitus—Topiramate—obesity	4.11e-05	0.000448	CcSEcCtD
Doxepin—Cardiac disorder—Topiramate—obesity	4.09e-05	0.000446	CcSEcCtD
Doxepin—Flushing—Topiramate—obesity	4.09e-05	0.000446	CcSEcCtD
Doxepin—Nortriptyline—HTR2C—obesity	4.06e-05	0.0208	CrCbGaD
Doxepin—Feeling abnormal—Bupropion—obesity	4.05e-05	0.000441	CcSEcCtD
Doxepin—Imipramine—SLC22A1—obesity	4.05e-05	0.0208	CrCbGaD
Doxepin—Asthenia—Sibutramine—obesity	4.05e-05	0.000441	CcSEcCtD
Doxepin—Gastrointestinal pain—Bupropion—obesity	4.02e-05	0.000438	CcSEcCtD
Doxepin—Angiopathy—Topiramate—obesity	4e-05	0.000436	CcSEcCtD
Doxepin—Pruritus—Sibutramine—obesity	3.99e-05	0.000435	CcSEcCtD
Doxepin—Diarrhoea—Orlistat—obesity	3.99e-05	0.000434	CcSEcCtD
Doxepin—Immune system disorder—Topiramate—obesity	3.98e-05	0.000434	CcSEcCtD
Doxepin—Mediastinal disorder—Topiramate—obesity	3.97e-05	0.000433	CcSEcCtD
Doxepin—Chills—Topiramate—obesity	3.96e-05	0.000431	CcSEcCtD
Doxepin—Urticaria—Bupropion—obesity	3.91e-05	0.000426	CcSEcCtD
Doxepin—Alopecia—Topiramate—obesity	3.9e-05	0.000425	CcSEcCtD
Doxepin—Abdominal pain—Bupropion—obesity	3.89e-05	0.000423	CcSEcCtD
Doxepin—Body temperature increased—Bupropion—obesity	3.89e-05	0.000423	CcSEcCtD
Doxepin—Mental disorder—Topiramate—obesity	3.86e-05	0.000421	CcSEcCtD
Doxepin—Diarrhoea—Sibutramine—obesity	3.86e-05	0.00042	CcSEcCtD
Doxepin—Dizziness—Orlistat—obesity	3.85e-05	0.00042	CcSEcCtD
Doxepin—Malnutrition—Topiramate—obesity	3.84e-05	0.000418	CcSEcCtD
Doxepin—Erythema—Topiramate—obesity	3.84e-05	0.000418	CcSEcCtD
Doxepin—Trimipramine—HTR2C—obesity	3.82e-05	0.0196	CrCbGaD
Doxepin—Promazine—DRD1—obesity	3.78e-05	0.0194	CrCbGaD
Doxepin—Flatulence—Topiramate—obesity	3.78e-05	0.000412	CcSEcCtD
Doxepin—Tension—Topiramate—obesity	3.77e-05	0.00041	CcSEcCtD
Doxepin—Dysgeusia—Topiramate—obesity	3.76e-05	0.00041	CcSEcCtD
Doxepin—Dizziness—Sibutramine—obesity	3.73e-05	0.000406	CcSEcCtD
Doxepin—Nervousness—Topiramate—obesity	3.73e-05	0.000406	CcSEcCtD
Doxepin—Back pain—Topiramate—obesity	3.71e-05	0.000405	CcSEcCtD
Doxepin—Vomiting—Orlistat—obesity	3.7e-05	0.000404	CcSEcCtD
Doxepin—Muscle spasms—Topiramate—obesity	3.69e-05	0.000402	CcSEcCtD
Doxepin—Rash—Orlistat—obesity	3.67e-05	0.0004	CcSEcCtD
Doxepin—Dermatitis—Orlistat—obesity	3.67e-05	0.0004	CcSEcCtD
Doxepin—Headache—Orlistat—obesity	3.65e-05	0.000398	CcSEcCtD
Doxepin—Desipramine—ADRB1—obesity	3.62e-05	0.0186	CrCbGaD
Doxepin—Hypersensitivity—Bupropion—obesity	3.62e-05	0.000395	CcSEcCtD
Doxepin—Vision blurred—Topiramate—obesity	3.62e-05	0.000394	CcSEcCtD
Doxepin—Tremor—Topiramate—obesity	3.6e-05	0.000392	CcSEcCtD
Doxepin—Vomiting—Sibutramine—obesity	3.59e-05	0.000391	CcSEcCtD
Doxepin—Ill-defined disorder—Topiramate—obesity	3.56e-05	0.000388	CcSEcCtD
Doxepin—Rash—Sibutramine—obesity	3.56e-05	0.000387	CcSEcCtD
Doxepin—Dermatitis—Sibutramine—obesity	3.55e-05	0.000387	CcSEcCtD
Doxepin—Anaemia—Topiramate—obesity	3.55e-05	0.000387	CcSEcCtD
Doxepin—Headache—Sibutramine—obesity	3.53e-05	0.000385	CcSEcCtD
Doxepin—Asthenia—Bupropion—obesity	3.53e-05	0.000384	CcSEcCtD
Doxepin—Agitation—Topiramate—obesity	3.53e-05	0.000384	CcSEcCtD
Doxepin—Pruritus—Bupropion—obesity	3.48e-05	0.000379	CcSEcCtD
Doxepin—Nausea—Orlistat—obesity	3.46e-05	0.000377	CcSEcCtD
Doxepin—Malaise—Topiramate—obesity	3.46e-05	0.000377	CcSEcCtD
Doxepin—Amitriptyline—HTR1B—obesity	3.45e-05	0.0177	CrCbGaD
Doxepin—Vertigo—Topiramate—obesity	3.45e-05	0.000376	CcSEcCtD
Doxepin—Syncope—Topiramate—obesity	3.44e-05	0.000375	CcSEcCtD
Doxepin—Clomipramine—SLC6A4—obesity	3.44e-05	0.0176	CrCbGaD
Doxepin—Leukopenia—Topiramate—obesity	3.44e-05	0.000374	CcSEcCtD
Doxepin—Chlorprothixene—DRD2—obesity	3.41e-05	0.0175	CrCbGaD
Doxepin—Palpitations—Topiramate—obesity	3.39e-05	0.00037	CcSEcCtD
Doxepin—Loss of consciousness—Topiramate—obesity	3.37e-05	0.000368	CcSEcCtD
Doxepin—Diarrhoea—Bupropion—obesity	3.36e-05	0.000367	CcSEcCtD
Doxepin—Nortriptyline—SLC6A4—obesity	3.36e-05	0.0172	CrCbGaD
Doxepin—Nausea—Sibutramine—obesity	3.35e-05	0.000365	CcSEcCtD
Doxepin—Cough—Topiramate—obesity	3.35e-05	0.000365	CcSEcCtD
Doxepin—Thiothixene—HTR2A—obesity	3.34e-05	0.0171	CrCbGaD
Doxepin—Nortriptyline—DRD2—obesity	3.34e-05	0.0171	CrCbGaD
Doxepin—Desipramine—HTR2C—obesity	3.34e-05	0.0171	CrCbGaD
Doxepin—Convulsion—Topiramate—obesity	3.33e-05	0.000362	CcSEcCtD
Doxepin—Hypertension—Topiramate—obesity	3.31e-05	0.000361	CcSEcCtD
Doxepin—Chest pain—Topiramate—obesity	3.27e-05	0.000356	CcSEcCtD
Doxepin—Myalgia—Topiramate—obesity	3.27e-05	0.000356	CcSEcCtD
Doxepin—Arthralgia—Topiramate—obesity	3.27e-05	0.000356	CcSEcCtD
Doxepin—Anxiety—Topiramate—obesity	3.26e-05	0.000355	CcSEcCtD
Doxepin—Dizziness—Bupropion—obesity	3.25e-05	0.000354	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	3.24e-05	0.000354	CcSEcCtD
Doxepin—Promazine—HTR2C—obesity	3.24e-05	0.0166	CrCbGaD
Doxepin—Discomfort—Topiramate—obesity	3.23e-05	0.000352	CcSEcCtD
Doxepin—Nortriptyline—CYP2E1—obesity	3.22e-05	0.0165	CrCbGaD
Doxepin—Dry mouth—Topiramate—obesity	3.2e-05	0.000348	CcSEcCtD
Doxepin—Trimipramine—SLC6A4—obesity	3.16e-05	0.0162	CrCbGaD
Doxepin—Confusional state—Topiramate—obesity	3.16e-05	0.000344	CcSEcCtD
Doxepin—Oxcarbazepine—ALB—obesity	3.15e-05	0.0161	CrCbGaD
Doxepin—Trimipramine—DRD2—obesity	3.15e-05	0.0161	CrCbGaD
Doxepin—Oedema—Topiramate—obesity	3.13e-05	0.000341	CcSEcCtD
Doxepin—Vomiting—Bupropion—obesity	3.13e-05	0.000341	CcSEcCtD
Doxepin—Infection—Topiramate—obesity	3.11e-05	0.000339	CcSEcCtD
Doxepin—Rash—Bupropion—obesity	3.1e-05	0.000338	CcSEcCtD
Doxepin—Dermatitis—Bupropion—obesity	3.1e-05	0.000337	CcSEcCtD
Doxepin—Shock—Topiramate—obesity	3.08e-05	0.000336	CcSEcCtD
Doxepin—Headache—Bupropion—obesity	3.08e-05	0.000336	CcSEcCtD
Doxepin—Nervous system disorder—Topiramate—obesity	3.07e-05	0.000335	CcSEcCtD
Doxepin—Thrombocytopenia—Topiramate—obesity	3.07e-05	0.000334	CcSEcCtD
Doxepin—Tachycardia—Topiramate—obesity	3.06e-05	0.000333	CcSEcCtD
Doxepin—Desipramine—ADRB2—obesity	3.05e-05	0.0156	CrCbGaD
Doxepin—Skin disorder—Topiramate—obesity	3.04e-05	0.000332	CcSEcCtD
Doxepin—Promethazine—DRD2—obesity	3.03e-05	0.0155	CrCbGaD
Doxepin—Hyperhidrosis—Topiramate—obesity	3.03e-05	0.00033	CcSEcCtD
Doxepin—Anorexia—Topiramate—obesity	2.99e-05	0.000325	CcSEcCtD
Doxepin—Hypotension—Topiramate—obesity	2.93e-05	0.000319	CcSEcCtD
Doxepin—Nausea—Bupropion—obesity	2.92e-05	0.000318	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Topiramate—obesity	2.85e-05	0.000311	CcSEcCtD
Doxepin—Insomnia—Topiramate—obesity	2.83e-05	0.000309	CcSEcCtD
Doxepin—Imipramine—HTR2C—obesity	2.83e-05	0.0145	CrCbGaD
Doxepin—Amitriptyline—HTR2C—obesity	2.82e-05	0.0144	CrCbGaD
Doxepin—Orphenadrine—CYP2E1—obesity	2.81e-05	0.0144	CrCbGaD
Doxepin—Paraesthesia—Topiramate—obesity	2.81e-05	0.000306	CcSEcCtD
Doxepin—Dyspnoea—Topiramate—obesity	2.79e-05	0.000304	CcSEcCtD
Doxepin—Somnolence—Topiramate—obesity	2.78e-05	0.000303	CcSEcCtD
Doxepin—Desipramine—SLC6A4—obesity	2.77e-05	0.0142	CrCbGaD
Doxepin—Dyspepsia—Topiramate—obesity	2.76e-05	0.0003	CcSEcCtD
Doxepin—Desipramine—DRD2—obesity	2.75e-05	0.0141	CrCbGaD
Doxepin—Decreased appetite—Topiramate—obesity	2.72e-05	0.000297	CcSEcCtD
Doxepin—Gastrointestinal disorder—Topiramate—obesity	2.7e-05	0.000295	CcSEcCtD
Doxepin—Fatigue—Topiramate—obesity	2.7e-05	0.000294	CcSEcCtD
Doxepin—Pain—Topiramate—obesity	2.68e-05	0.000292	CcSEcCtD
Doxepin—Constipation—Topiramate—obesity	2.68e-05	0.000292	CcSEcCtD
Doxepin—Promazine—DRD2—obesity	2.67e-05	0.0137	CrCbGaD
Doxepin—Desipramine—CYP2E1—obesity	2.65e-05	0.0136	CrCbGaD
Doxepin—Clomipramine—HTR2A—obesity	2.64e-05	0.0135	CrCbGaD
Doxepin—Chlorprothixene—HTR2A—obesity	2.63e-05	0.0135	CrCbGaD
Doxepin—Nortriptyline—HTR2A—obesity	2.58e-05	0.0132	CrCbGaD
Doxepin—Feeling abnormal—Topiramate—obesity	2.58e-05	0.000281	CcSEcCtD
Doxepin—Gastrointestinal pain—Topiramate—obesity	2.56e-05	0.000279	CcSEcCtD
Doxepin—Urticaria—Topiramate—obesity	2.49e-05	0.000271	CcSEcCtD
Doxepin—Abdominal pain—Topiramate—obesity	2.48e-05	0.00027	CcSEcCtD
Doxepin—Body temperature increased—Topiramate—obesity	2.48e-05	0.00027	CcSEcCtD
Doxepin—Trimipramine—HTR2A—obesity	2.43e-05	0.0125	CrCbGaD
Doxepin—Imipramine—SLC6A4—obesity	2.35e-05	0.012	CrCbGaD
Doxepin—Promethazine—HTR2A—obesity	2.34e-05	0.012	CrCbGaD
Doxepin—Imipramine—DRD2—obesity	2.33e-05	0.012	CrCbGaD
Doxepin—Amitriptyline—SLC6A4—obesity	2.33e-05	0.012	CrCbGaD
Doxepin—Amitriptyline—DRD2—obesity	2.32e-05	0.0119	CrCbGaD
Doxepin—Hypersensitivity—Topiramate—obesity	2.31e-05	0.000251	CcSEcCtD
Doxepin—Thiothixene—ALB—obesity	2.29e-05	0.0117	CrCbGaD
Doxepin—Asthenia—Topiramate—obesity	2.25e-05	0.000245	CcSEcCtD
Doxepin—Imipramine—CYP2E1—obesity	2.25e-05	0.0115	CrCbGaD
Doxepin—Amitriptyline—CYP2E1—obesity	2.23e-05	0.0114	CrCbGaD
Doxepin—Pruritus—Topiramate—obesity	2.22e-05	0.000241	CcSEcCtD
Doxepin—Diarrhoea—Topiramate—obesity	2.14e-05	0.000234	CcSEcCtD
Doxepin—Desipramine—HTR2A—obesity	2.13e-05	0.0109	CrCbGaD
Doxepin—Dizziness—Topiramate—obesity	2.07e-05	0.000226	CcSEcCtD
Doxepin—Promazine—HTR2A—obesity	2.06e-05	0.0106	CrCbGaD
Doxepin—Vomiting—Topiramate—obesity	1.99e-05	0.000217	CcSEcCtD
Doxepin—Rash—Topiramate—obesity	1.97e-05	0.000215	CcSEcCtD
Doxepin—Dermatitis—Topiramate—obesity	1.97e-05	0.000215	CcSEcCtD
Doxepin—Headache—Topiramate—obesity	1.96e-05	0.000214	CcSEcCtD
Doxepin—Nausea—Topiramate—obesity	1.86e-05	0.000203	CcSEcCtD
Doxepin—Clomipramine—ALB—obesity	1.81e-05	0.00927	CrCbGaD
Doxepin—Imipramine—HTR2A—obesity	1.8e-05	0.00924	CrCbGaD
Doxepin—Amitriptyline—HTR2A—obesity	1.79e-05	0.00919	CrCbGaD
Doxepin—Nortriptyline—ALB—obesity	1.77e-05	0.00906	CrCbGaD
Doxepin—Amitriptyline—ALB—obesity	1.23e-05	0.00629	CrCbGaD
Doxepin—HTR1A—Signaling Pathways—MAPK8—obesity	4.96e-07	6.18e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—obesity	4.94e-07	6.16e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—obesity	4.93e-07	6.14e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK8—obesity	4.93e-07	6.14e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NCOA1—obesity	4.92e-07	6.14e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARG—obesity	4.92e-07	6.13e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—obesity	4.92e-07	6.13e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.87e-07	6.07e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—obesity	4.85e-07	6.05e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP19A1—obesity	4.85e-07	6.05e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—STK11—obesity	4.85e-07	6.05e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—POMC—obesity	4.85e-07	6.04e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MYC—obesity	4.83e-07	6.02e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—PIK3CA—obesity	4.83e-07	6.02e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—INS—obesity	4.82e-07	6.01e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—obesity	4.82e-07	6e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—obesity	4.8e-07	5.98e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK8—obesity	4.8e-07	5.98e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—obesity	4.78e-07	5.96e-06	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—obesity	4.78e-07	5.95e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—PIK3CA—obesity	4.76e-07	5.93e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—POMC—obesity	4.73e-07	5.9e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—obesity	4.73e-07	5.89e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK8—obesity	4.72e-07	5.88e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—INS—obesity	4.71e-07	5.87e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—obesity	4.71e-07	5.86e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—obesity	4.7e-07	5.86e-06	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—obesity	4.7e-07	5.86e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—STAT3—obesity	4.69e-07	5.85e-06	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—obesity	4.69e-07	5.85e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CG—obesity	4.69e-07	5.84e-06	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—obesity	4.68e-07	5.83e-06	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—obesity	4.66e-07	5.81e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CG—obesity	4.65e-07	5.79e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARA—obesity	4.64e-07	5.78e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—obesity	4.63e-07	5.77e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—obesity	4.62e-07	5.75e-06	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—obesity	4.62e-07	5.75e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CB—obesity	4.61e-07	5.74e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MTOR—obesity	4.61e-07	5.74e-06	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—obesity	4.6e-07	5.74e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—obesity	4.6e-07	5.74e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—obesity	4.59e-07	5.72e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PIK3CA—obesity	4.55e-07	5.68e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—obesity	4.54e-07	5.66e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—obesity	4.53e-07	5.65e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—STAT3—obesity	4.53e-07	5.65e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—obesity	4.52e-07	5.64e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—COMT—obesity	4.51e-07	5.62e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—STAT3—obesity	4.51e-07	5.62e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AGT—obesity	4.49e-07	5.59e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—obesity	4.48e-07	5.59e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CD—obesity	4.48e-07	5.58e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—obesity	4.47e-07	5.58e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—POMC—obesity	4.46e-07	5.56e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARGC1A—obesity	4.45e-07	5.54e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GNB3—obesity	4.45e-07	5.54e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—INS—obesity	4.44e-07	5.53e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HMOX1—obesity	4.43e-07	5.52e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—POMC—obesity	4.42e-07	5.51e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—obesity	4.42e-07	5.51e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PIK3CA—obesity	4.41e-07	5.49e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—obesity	4.4e-07	5.49e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—obesity	4.4e-07	5.48e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—INS—obesity	4.4e-07	5.48e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—obesity	4.39e-07	5.47e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—obesity	4.38e-07	5.46e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—obesity	4.38e-07	5.46e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CD—obesity	4.37e-07	5.45e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—obesity	4.36e-07	5.44e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PIK3CA—obesity	4.36e-07	5.43e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—obesity	4.36e-07	5.43e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CAV1—obesity	4.36e-07	5.43e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK8—obesity	4.35e-07	5.42e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—obesity	4.35e-07	5.42e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOA1—obesity	4.35e-07	5.42e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—obesity	4.34e-07	5.41e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GNAS—obesity	4.33e-07	5.4e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—obesity	4.32e-07	5.39e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—obesity	4.32e-07	5.38e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—obesity	4.31e-07	5.38e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—obesity	4.31e-07	5.37e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK8—obesity	4.28e-07	5.33e-06	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—obesity	4.28e-07	5.33e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—obesity	4.28e-07	5.33e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK8—obesity	4.27e-07	5.32e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—obesity	4.27e-07	5.32e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—obesity	4.26e-07	5.31e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK8—obesity	4.26e-07	5.31e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—obesity	4.25e-07	5.29e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK8—obesity	4.25e-07	5.29e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOB—obesity	4.24e-07	5.29e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—obesity	4.23e-07	5.28e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3R1—obesity	4.23e-07	5.27e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—obesity	4.23e-07	5.27e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—obesity	4.21e-07	5.25e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—obesity	4.21e-07	5.25e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK8—obesity	4.2e-07	5.24e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—obesity	4.2e-07	5.23e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—obesity	4.19e-07	5.22e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK8—obesity	4.19e-07	5.22e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—obesity	4.19e-07	5.22e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—obesity	4.18e-07	5.21e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—obesity	4.18e-07	5.21e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.16e-07	5.19e-06	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—obesity	4.14e-07	5.15e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—obesity	4.13e-07	5.14e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3R1—obesity	4.13e-07	5.14e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CD—obesity	4.12e-07	5.13e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—obesity	4.1e-07	5.11e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CD—obesity	4.08e-07	5.09e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—obesity	4.07e-07	5.08e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—obesity	4.07e-07	5.07e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—obesity	4.06e-07	5.06e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—LPL—obesity	4.05e-07	5.05e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—obesity	4.03e-07	5.03e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—obesity	4.03e-07	5.02e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—obesity	4.01e-07	5e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—obesity	4.01e-07	4.99e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—obesity	4e-07	4.98e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—obesity	3.98e-07	4.96e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CG—obesity	3.97e-07	4.95e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GPX1—obesity	3.95e-07	4.92e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—obesity	3.94e-07	4.91e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—obesity	3.91e-07	4.88e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—obesity	3.91e-07	4.87e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CB—obesity	3.9e-07	4.86e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—obesity	3.9e-07	4.86e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK8—obesity	3.9e-07	4.85e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—obesity	3.89e-07	4.85e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3R1—obesity	3.89e-07	4.85e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—obesity	3.89e-07	4.85e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—obesity	3.88e-07	4.84e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—obesity	3.88e-07	4.84e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—obesity	3.87e-07	4.82e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—obesity	3.86e-07	4.81e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3R1—obesity	3.86e-07	4.81e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—obesity	3.86e-07	4.81e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CD36—obesity	3.85e-07	4.8e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—obesity	3.84e-07	4.79e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—obesity	3.83e-07	4.78e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—obesity	3.83e-07	4.77e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CB—obesity	3.81e-07	4.75e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—POMC—obesity	3.78e-07	4.71e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—obesity	3.78e-07	4.7e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—INS—obesity	3.76e-07	4.68e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—obesity	3.72e-07	4.64e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—obesity	3.7e-07	4.61e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—obesity	3.7e-07	4.61e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—obesity	3.69e-07	4.59e-06	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—obesity	3.66e-07	4.56e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—obesity	3.65e-07	4.54e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—obesity	3.64e-07	4.53e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—obesity	3.63e-07	4.52e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—obesity	3.63e-07	4.52e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—obesity	3.63e-07	4.52e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—obesity	3.62e-07	4.51e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—obesity	3.62e-07	4.51e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—obesity	3.61e-07	4.5e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—obesity	3.61e-07	4.49e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—obesity	3.6e-07	4.49e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—obesity	3.6e-07	4.48e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CB—obesity	3.59e-07	4.47e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARA—obesity	3.58e-07	4.46e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—obesity	3.57e-07	4.45e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—obesity	3.57e-07	4.45e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—obesity	3.56e-07	4.44e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—obesity	3.56e-07	4.44e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—obesity	3.56e-07	4.44e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—obesity	3.56e-07	4.44e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CB—obesity	3.56e-07	4.44e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—obesity	3.56e-07	4.43e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—obesity	3.56e-07	4.43e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—obesity	3.55e-07	4.43e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—obesity	3.53e-07	4.4e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CD—obesity	3.49e-07	4.35e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AGT—obesity	3.47e-07	4.32e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—obesity	3.46e-07	4.31e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—obesity	3.45e-07	4.29e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—obesity	3.4e-07	4.24e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—obesity	3.4e-07	4.23e-06	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—obesity	3.38e-07	4.21e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAV1—obesity	3.36e-07	4.19e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—obesity	3.36e-07	4.19e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOA1—obesity	3.36e-07	4.18e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—obesity	3.35e-07	4.17e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—obesity	3.31e-07	4.12e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—obesity	3.3e-07	4.11e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—obesity	3.3e-07	4.11e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3R1—obesity	3.3e-07	4.11e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—obesity	3.28e-07	4.09e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—obesity	3.16e-07	3.94e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—obesity	3.15e-07	3.92e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—obesity	3.14e-07	3.91e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—obesity	3.09e-07	3.85e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—obesity	3.08e-07	3.84e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—obesity	3.07e-07	3.83e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CG—obesity	3.06e-07	3.82e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—obesity	3.06e-07	3.82e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—obesity	3.06e-07	3.81e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CB—obesity	3.04e-07	3.79e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—obesity	3.03e-07	3.78e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—obesity	3.02e-07	3.77e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—obesity	3.02e-07	3.77e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—obesity	3.01e-07	3.76e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—obesity	3.01e-07	3.76e-06	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—obesity	2.99e-07	3.73e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—obesity	2.96e-07	3.68e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—obesity	2.92e-07	3.64e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—POMC—obesity	2.92e-07	3.63e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—obesity	2.9e-07	3.62e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—INS—obesity	2.9e-07	3.61e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—obesity	2.83e-07	3.52e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—obesity	2.81e-07	3.5e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—obesity	2.78e-07	3.46e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—obesity	2.78e-07	3.46e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—obesity	2.74e-07	3.42e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—obesity	2.73e-07	3.41e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—obesity	2.73e-07	3.4e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—obesity	2.72e-07	3.39e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—obesity	2.71e-07	3.38e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CD—obesity	2.69e-07	3.36e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—obesity	2.68e-07	3.34e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—obesity	2.68e-07	3.34e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—obesity	2.66e-07	3.31e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—obesity	2.56e-07	3.19e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3R1—obesity	2.54e-07	3.17e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—obesity	2.54e-07	3.17e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—obesity	2.52e-07	3.14e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—obesity	2.52e-07	3.14e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—obesity	2.51e-07	3.13e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—obesity	2.5e-07	3.12e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—obesity	2.49e-07	3.1e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—obesity	2.48e-07	3.09e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—obesity	2.47e-07	3.08e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—obesity	2.38e-07	2.97e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CB—obesity	2.35e-07	2.93e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—obesity	2.33e-07	2.9e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—obesity	2.32e-07	2.89e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—obesity	2.29e-07	2.86e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—obesity	2.19e-07	2.73e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—obesity	2.17e-07	2.7e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—obesity	1.94e-07	2.42e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—obesity	1.9e-07	2.36e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—obesity	1.85e-07	2.31e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—obesity	1.79e-07	2.23e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—obesity	1.77e-07	2.21e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—obesity	1.51e-07	1.89e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—obesity	1.43e-07	1.78e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—obesity	1.17e-07	1.46e-06	CbGpPWpGaD
